5057-12-5 Usage
Description
4,6,7,8-TETRAHYDRO-1H,3H-QUINOLINE-2,5-DIONE, also known as 4,6,7,8-Tetrahydro-2,5(1H,3H)-quinolinedione, is an organic compound with the chemical formula C9H11NO2. It is a heterocyclic compound that belongs to the quinolone family and is characterized by its unique structure and properties.
Uses
Used in Organic Synthesis:
4,6,7,8-TETRAHYDRO-1H,3H-QUINOLINE-2,5-DIONE is used as a key intermediate in the synthesis of various organic compounds. Its unique structure and reactivity make it a valuable building block for the development of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4,6,7,8-TETRAHYDRO-1H,3H-QUINOLINE-2,5-DIONE is used as a starting material for the synthesis of various drug candidates. Its versatile chemistry allows for the development of novel therapeutic agents with potential applications in treating a wide range of diseases and conditions.
Used in Agrochemical Industry:
4,6,7,8-TETRAHYDRO-1H,3H-QUINOLINE-2,5-DIONE is also utilized in the agrochemical industry for the synthesis of various crop protection agents. Its unique properties enable the development of innovative and effective solutions for pest control and crop management.
Used in Specialty Chemicals:
In the specialty chemicals sector, 4,6,7,8-TETRAHYDRO-1H,3H-QUINOLINE-2,5-DIONE is employed as a key component in the synthesis of various high-value products. Its unique structure and reactivity contribute to the development of advanced materials with specific properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 5057-12-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,5 and 7 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5057-12:
(6*5)+(5*0)+(4*5)+(3*7)+(2*1)+(1*2)=75
75 % 10 = 5
So 5057-12-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO2/c11-8-3-1-2-7-6(8)4-5-9(12)10-7/h1-5H2,(H,10,12)
5057-12-5Relevant articles and documents
Stable carteolol hydrochloride, preparation method thereof and eye medicine combination
-
, (2017/12/06)
The invention relates to stable carteolol hydrochloride, a preparation method thereof and an eye medicine combination, in particular to a method for preparing carteolol hydrochloride. The method comprises the following steps of preparing 3-amino-2-cyclohexenone, tetrahydro-2,5(1H, 6H)-quinolinone, 5-hydroxy-3,4-dihydro-2(1H)-carbostyril and 5-(2,3-epoxypropoxy)-3,4-dihydro-2(1H)-carbostyril, and then the carteolol hydrochloride is obtained. Furthermore, the invention provides the carteolol hydrochloride crude medicine obtained according to the method, the eye medicine combination prepared by using the obtained carteolol hydrochloride as the crude medicine, and applications of the obtained carteolol hydrochloride to preparation of drugs for treating or preventing glaucoma or ocular hypertension. The method has excellent pharmaceutical characteristics, for example, the obtained crude medicine and a preparation has excellent stability.
Pharmaceutical compositions containing quinolin-2,5-diones, new quinolin-2,5-diones and processes for the preparation thereof
-
, (2008/06/13)
This invention relates to pharmaceutical compositions containing quinolin-2,5-diones of formula STR1 wherein A, B, R1 to R3 and X are defined hereinbelow, some of which are novel, which compounds have valuable pharmacological propert
